A noninternalized nondesensitized truncated AT1A receptor transduces an amplified ANG II signal

S Conchon1, N Peltier, P Corvol

  • 1Institut National de la Santé et de la Recherche Médicale Unité 36, Collège de France, Paris, France.

Insights

Researchers studied rat angiotensin II AT1A receptor mutants to understand internalization and desensitization. A specific mutant (delta 329) showed impaired internalization and desensitization, leading to amplified cellular responses.

Area of Science:

  • Molecular Pharmacology
  • Cell Signaling
  • Receptor Biology

Background:

  • The angiotensin II AT1A receptor plays a crucial role in cardiovascular regulation.
  • Receptor internalization and desensitization are key mechanisms modulating cellular responses to angiotensin II.
  • Understanding the structural basis of these processes is vital for developing targeted therapies.

Purpose of the Study:

  • To identify structural determinants within the cytoplasmic tail of the rat AT1A receptor responsible for internalization and desensitization.
  • To investigate the functional consequences of impaired internalization and desensitization on receptor signaling.
  • To characterize a novel AT1A receptor mutant with altered desensitization and internalization properties.

Main Methods:

  • Generation of six rat AT1A receptor mutants with progressive deletions in the cytoplasmic tail.
  • Stable transfection into Chinese hamster ovary cells and assessment of [Sar1]ANG II binding affinities (Kd).
  • Measurement of ANG II-induced inositol phosphate (IP) turnover, receptor internalization (acid-washing), and desensitization (ANG II or phorbol ester pretreatment).

Main Results:

  • Most mutants retained normal ligand binding affinities and Gq/11 protein/phospholipase C activation.
  • The delta 329 mutant (31 residue deletion) exhibited significantly reduced ligand-induced internalization (32% vs. 83% WT).
  • Delta 329 displayed diminished desensitization to ANG II (15% vs. 60% WT) and phorbol ester (0% vs. 29% WT), coupled with amplified signaling.

Conclusions:

  • The sequence 329SLSTKMS335 in the rat AT1A receptor cytoplasmic tail is critical for receptor internalization and desensitization.
  • A mutant defective in desensitization and internalization (delta 329) demonstrates hyperreactivity and augmented cellular responses.
  • This study provides the first evidence linking impaired AT1A receptor desensitization/internalization to enhanced signaling and cellular effects.

Related Concept Videos

Intracellular Signaling Cascades01:43

Intracellular Signaling Cascades

Once a ligand binds to a receptor, the signal is transmitted through the membrane and into the cytoplasm. The continuation of a signal in this manner is called signal transduction. Signal transduction only occurs with cell-surface receptors, which cannot interact with most components of the cell, such as DNA. Only internal receptors can interact directly with DNA in the nucleus to initiate protein synthesis. When a ligand binds to its receptor, conformational changes occur that affect the...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Signal Transduction: Overview01:26

Signal Transduction: Overview

Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...